nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxymesterone—PRLR—Nuclear signaling by ERBB4—GFAP—Parkinson's disease	0.0452	0.0678	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—DLG4—Parkinson's disease	0.0321	0.0482	CbGpPWpGaD
Fluoxymesterone—PRLR—ErbB4 signaling events—GRIN2B—Parkinson's disease	0.0314	0.0471	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—INSR—Parkinson's disease	0.0278	0.0418	CbGpPWpGaD
Fluoxymesterone—PRLR—brain—Parkinson's disease	0.0258	0.0839	CbGeAlD
Fluoxymesterone—SHBG—hindbrain—Parkinson's disease	0.0243	0.079	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptors—NR4A2—Parkinson's disease	0.0172	0.0259	CbGpPWpGaD
Fluoxymesterone—ESR1—hindbrain—Parkinson's disease	0.0171	0.0556	CbGeAlD
Fluoxymesterone—NR3C1—nerve—Parkinson's disease	0.0168	0.0548	CbGeAlD
Fluoxymesterone—PRLR—Signaling by ERBB4—GFAP—Parkinson's disease	0.0152	0.0228	CbGpPWpGaD
Fluoxymesterone—SHBG—brainstem—Parkinson's disease	0.0139	0.0453	CbGeAlD
Fluoxymesterone—AR—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0136	0.0205	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0133	0.0199	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—FGF20—Parkinson's disease	0.0132	0.0198	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptors—NR4A2—Parkinson's disease	0.0131	0.0196	CbGpPWpGaD
Fluoxymesterone—NR3C1—hindbrain—Parkinson's disease	0.0126	0.041	CbGeAlD
Fluoxymesterone—PRLR—Signaling events mediated by PTP1B—INS—Parkinson's disease	0.0123	0.0185	CbGpPWpGaD
Fluoxymesterone—SHBG—cardiovascular system—Parkinson's disease	0.0113	0.0369	CbGeAlD
Fluoxymesterone—ESR1—embryo—Parkinson's disease	0.0107	0.0348	CbGeAlD
Fluoxymesterone—ESR1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0105	0.0158	CbGpPWpGaD
Fluoxymesterone—NR3C1—Nuclear Receptor transcription pathway—NR4A2—Parkinson's disease	0.0103	0.0155	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—INSR—Parkinson's disease	0.0102	0.0154	CbGpPWpGaD
Fluoxymesterone—ESR1—brainstem—Parkinson's disease	0.0098	0.0319	CbGeAlD
Fluoxymesterone—AR—forebrain—Parkinson's disease	0.00963	0.0313	CbGeAlD
Fluoxymesterone—ESR1—forebrain—Parkinson's disease	0.00945	0.0308	CbGeAlD
Fluoxymesterone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—Parkinson's disease	0.00916	0.0138	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HLA-DRA—Parkinson's disease	0.00903	0.0136	CbGpPWpGaD
Fluoxymesterone—AR—Androgen receptor signaling pathway—PARK7—Parkinson's disease	0.00873	0.0131	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00865	0.013	CbGpPWpGaD
Fluoxymesterone—ESR1—Nuclear signaling by ERBB4—GFAP—Parkinson's disease	0.00848	0.0127	CbGpPWpGaD
Fluoxymesterone—AR—cardiovascular system—Parkinson's disease	0.00814	0.0265	CbGeAlD
Fluoxymesterone—ESR1—cardiovascular system—Parkinson's disease	0.00799	0.026	CbGeAlD
Fluoxymesterone—Testosterone Propionate—COMT—Parkinson's disease	0.00797	0.297	CrCbGaD
Fluoxymesterone—NR3C1—embryo—Parkinson's disease	0.00789	0.0257	CbGeAlD
Fluoxymesterone—NR3C1—brainstem—Parkinson's disease	0.00723	0.0235	CbGeAlD
Fluoxymesterone—SHBG—central nervous system—Parkinson's disease	0.00701	0.0228	CbGeAlD
Fluoxymesterone—NR3C1—forebrain—Parkinson's disease	0.00698	0.0227	CbGeAlD
Fluoxymesterone—SHBG—cerebellum—Parkinson's disease	0.00685	0.0223	CbGeAlD
Fluoxymesterone—ESR1—LKB1 signaling events—MAPT—Parkinson's disease	0.00674	0.0101	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—EN1—Parkinson's disease	0.00656	0.00985	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00655	0.00984	CbGpPWpGaD
Fluoxymesterone—AR—spinal cord—Parkinson's disease	0.0062	0.0202	CbGeAlD
Fluoxymesterone—ESR1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00617	0.00927	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—PENK—Parkinson's disease	0.00608	0.00913	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—INS—Parkinson's disease	0.00592	0.00888	CbGpPWpGaD
Fluoxymesterone—NR3C1—cardiovascular system—Parkinson's disease	0.0059	0.0192	CbGeAlD
Fluoxymesterone—SHBG—brain—Parkinson's disease	0.00557	0.0181	CbGeAlD
Fluoxymesterone—ESR1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00552	0.00828	CbGpPWpGaD
Fluoxymesterone—AR—head—Parkinson's disease	0.00551	0.018	CbGeAlD
Fluoxymesterone—AR—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.00544	0.00817	CbGpPWpGaD
Fluoxymesterone—NR3C1—Signaling events mediated by HDAC Class II—ADRBK1—Parkinson's disease	0.00543	0.00816	CbGpPWpGaD
Fluoxymesterone—ESR1—head—Parkinson's disease	0.00541	0.0176	CbGeAlD
Fluoxymesterone—AR—nervous system—Parkinson's disease	0.00523	0.017	CbGeAlD
Fluoxymesterone—ESR1—nervous system—Parkinson's disease	0.00513	0.0167	CbGeAlD
Fluoxymesterone—ESR1—FOXM1 transcription factor network—HSPA1A—Parkinson's disease	0.00505	0.00759	CbGpPWpGaD
Fluoxymesterone—NR3C1—medulla oblongata—Parkinson's disease	0.00504	0.0164	CbGeAlD
Fluoxymesterone—AR—central nervous system—Parkinson's disease	0.00503	0.0164	CbGeAlD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—ATP1A3—Parkinson's disease	0.00497	0.00746	CbGpPWpGaD
Fluoxymesterone—ESR1—central nervous system—Parkinson's disease	0.00494	0.0161	CbGeAlD
Fluoxymesterone—ESR1—cerebellum—Parkinson's disease	0.00483	0.0157	CbGeAlD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—NQO1—Parkinson's disease	0.00473	0.00711	CbGpPWpGaD
Fluoxymesterone—NR3C1—midbrain—Parkinson's disease	0.00461	0.015	CbGeAlD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—HGF—Parkinson's disease	0.00456	0.00684	CbGpPWpGaD
Fluoxymesterone—NR3C1—spinal cord—Parkinson's disease	0.00449	0.0146	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—VPS35—Parkinson's disease	0.00429	0.00644	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00426	0.0064	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—SOD1—Parkinson's disease	0.00419	0.00629	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.00409	0.00614	CbGpPWpGaD
Fluoxymesterone—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—Parkinson's disease	0.00407	0.00612	CbGpPWpGaD
Fluoxymesterone—AR—brain—Parkinson's disease	0.004	0.013	CbGeAlD
Fluoxymesterone—NR3C1—head—Parkinson's disease	0.00399	0.013	CbGeAlD
Fluoxymesterone—ESR1—brain—Parkinson's disease	0.00392	0.0128	CbGeAlD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—TH—Parkinson's disease	0.00382	0.00574	CbGpPWpGaD
Fluoxymesterone—NR3C1—nervous system—Parkinson's disease	0.00379	0.0123	CbGeAlD
Fluoxymesterone—NR3C1—central nervous system—Parkinson's disease	0.00365	0.0119	CbGeAlD
Fluoxymesterone—NR3C1—cerebellum—Parkinson's disease	0.00356	0.0116	CbGeAlD
Fluoxymesterone—PRLR—Signaling Pathways—GPR37—Parkinson's disease	0.00355	0.00534	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DGKQ—Parkinson's disease	0.00355	0.00534	CbGpPWpGaD
Fluoxymesterone—AR—FOXA1 transcription factor network—INS—Parkinson's disease	0.00343	0.00515	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—TH—Parkinson's disease	0.00333	0.00501	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—TH—Parkinson's disease	0.00328	0.00493	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00328	0.00493	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00325	0.00488	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—DCTN1—Parkinson's disease	0.00324	0.00487	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of nuclear SMAD2/3 signaling—HSPA8—Parkinson's disease	0.00323	0.00485	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—TNF—Parkinson's disease	0.0032	0.00481	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.0032	0.00481	CbGpPWpGaD
Fluoxymesterone—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—Parkinson's disease	0.00311	0.00466	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—DDC—Parkinson's disease	0.0031	0.00466	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—MAPK8—Parkinson's disease	0.0031	0.00466	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HLA-DRA—Parkinson's disease	0.00295	0.00443	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PLA2G6—Parkinson's disease	0.00292	0.00438	CbGpPWpGaD
Fluoxymesterone—NR3C1—brain—Parkinson's disease	0.00289	0.00942	CbGeAlD
Fluoxymesterone—ESR1—Signaling by ERBB4—GFAP—Parkinson's disease	0.00286	0.00429	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—RIT2—Parkinson's disease	0.00284	0.00427	CbGpPWpGaD
Fluoxymesterone—ESR1—Regulation of Telomerase—ABL1—Parkinson's disease	0.00282	0.00424	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00275	0.00413	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRK5—Parkinson's disease	0.00269	0.00405	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—PARK2—Parkinson's disease	0.00266	0.004	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00266	0.00399	CbGpPWpGaD
Fluoxymesterone—Megestrol acetate—ABCB1—Parkinson's disease	0.00266	0.0988	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00265	0.00398	CbGpPWpGaD
Fluoxymesterone—ESR1—FOXA1 transcription factor network—INS—Parkinson's disease	0.00264	0.00397	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—FGF20—Parkinson's disease	0.00264	0.00397	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00262	0.00394	CbGpPWpGaD
Fluoxymesterone—Testosterone—MAOA—Parkinson's disease	0.00261	0.0971	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00261	0.00392	CbGpPWpGaD
Fluoxymesterone—NR3C1—FOXA2 and FOXA3 transcription factor networks—INS—Parkinson's disease	0.0026	0.00391	CbGpPWpGaD
Fluoxymesterone—PRLR—Adipogenesis—IL6—Parkinson's disease	0.00258	0.00388	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—EDN1—Parkinson's disease	0.00258	0.00388	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—FGF20—Parkinson's disease	0.00248	0.00372	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.00247	0.0037	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—TNF—Parkinson's disease	0.00245	0.00368	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRM4—Parkinson's disease	0.00242	0.00363	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL1B—Parkinson's disease	0.00239	0.00359	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00235	0.00353	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PENK—Parkinson's disease	0.00229	0.00344	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAG—Parkinson's disease	0.00229	0.00344	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling by ERBB4—IL6—Parkinson's disease	0.00228	0.00343	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00228	0.00342	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—PDYN—Parkinson's disease	0.0021	0.00315	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—INS—Parkinson's disease	0.00209	0.00314	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.00209	0.00313	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.00205	0.00307	CbGpPWpGaD
Fluoxymesterone—AR—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00202	0.00304	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.00201	0.00302	CbGpPWpGaD
Fluoxymesterone—NR3C1—Transcription factor regulation in adipogenesis—IL6—Parkinson's disease	0.00198	0.00297	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.00198	0.00297	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GFAP—Parkinson's disease	0.00197	0.00296	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—GRM5—Parkinson's disease	0.00195	0.00292	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ADRBK1—Parkinson's disease	0.00194	0.00292	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00194	0.00291	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00192	0.00289	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00186	0.00279	CbGpPWpGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00181	0.00272	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—NR4A2—Parkinson's disease	0.00179	0.00268	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.00173	0.0026	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGF20—Parkinson's disease	0.00171	0.00256	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADORA2A—Parkinson's disease	0.00166	0.00249	CbGpPWpGaD
Fluoxymesterone—Spironolactone—ABCB1—Parkinson's disease	0.00165	0.0614	CrCbGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00165	0.00248	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—PRKRA—Parkinson's disease	0.00161	0.00242	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.0016	0.00241	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—ABL1—Parkinson's disease	0.00158	0.00238	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00158	0.00237	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00157	0.00236	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2E1—Parkinson's disease	0.00156	0.058	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.00155	0.00233	CbGpPWpGaD
Fluoxymesterone—NR3C1—Regulation of Androgen receptor activity—MAPK8—Parkinson's disease	0.00153	0.0023	CbGpPWpGaD
Fluoxymesterone—Norethindrone—ABCB1—Parkinson's disease	0.00153	0.0571	CrCbGaD
Fluoxymesterone—PRLR—Signaling Pathways—INSR—Parkinson's disease	0.00153	0.0023	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—ABL1—Parkinson's disease	0.00149	0.00224	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—HGF—Parkinson's disease	0.00149	0.00223	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.00146	0.00219	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—FGB—Parkinson's disease	0.00144	0.00217	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR1A—Parkinson's disease	0.00144	0.00216	CbGpPWpGaD
Fluoxymesterone—Prednisolone—ABCB1—Parkinson's disease	0.00143	0.0534	CrCbGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—MAPK8—Parkinson's disease	0.00143	0.00215	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—TAC1—Parkinson's disease	0.00142	0.00213	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.00141	0.00212	CbGpPWpGaD
Fluoxymesterone—Betamethasone—ABCB1—Parkinson's disease	0.0014	0.0523	CrCbGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.0014	0.00211	CbGpPWpGaD
Fluoxymesterone—PRLR—Cytokine Signaling in Immune system—IL6—Parkinson's disease	0.0014	0.0021	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DRD1—Parkinson's disease	0.00139	0.00208	CbGpPWpGaD
Fluoxymesterone—ESR1—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.00138	0.00207	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DRD3—Parkinson's disease	0.00134	0.00202	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—IL1B—Parkinson's disease	0.00129	0.00193	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—ADRBK1—Parkinson's disease	0.00126	0.00188	CbGpPWpGaD
Fluoxymesterone—Progesterone—CYP2D6—Parkinson's disease	0.00125	0.0466	CrCbGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.00125	0.00188	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—PRKRA—Parkinson's disease	0.00124	0.00186	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	0.00124	0.00186	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—PRKRA—Parkinson's disease	0.00122	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	0.00122	0.00183	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR7—Parkinson's disease	0.00122	0.00183	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—DRD2—Parkinson's disease	0.00122	0.00183	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	0.0012	0.0018	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.00119	0.00179	CbGpPWpGaD
Fluoxymesterone—ESR1—Leptin signaling pathway—MAPK8—Parkinson's disease	0.00118	0.00177	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—CYP2D6—Parkinson's disease	0.00114	0.0426	CrCbGaD
Fluoxymesterone—AR—Gene Expression—NR4A2—Parkinson's disease	0.00113	0.0017	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—TAF1—Parkinson's disease	0.00113	0.0017	CbGpPWpGaD
Fluoxymesterone—Hydrocortisone—ABCB1—Parkinson's disease	0.0011	0.0408	CrCbGaD
Fluoxymesterone—NR3C1—Adipogenesis—INS—Parkinson's disease	0.00109	0.00164	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—Parkinson's disease	0.00108	0.00163	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	0.00108	0.00162	CbGpPWpGaD
Fluoxymesterone—AR—Generic Transcription Pathway—CTGF—Parkinson's disease	0.00106	0.00159	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF2—Parkinson's disease	0.00102	0.00153	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IGF1R—Parkinson's disease	0.000985	0.00148	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—EDN1—Parkinson's disease	0.000973	0.00146	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000952	0.00143	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.00093	0.0014	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000928	0.00139	CbGpPWpGaD
Fluoxymesterone—ESR1—ATF-2 transcription factor network—IL6—Parkinson's disease	0.000913	0.00137	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL6—Parkinson's disease	0.000906	0.00136	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—NGF—Parkinson's disease	0.000894	0.00134	CbGpPWpGaD
Fluoxymesterone—Progesterone—ABCB1—Parkinson's disease	0.000893	0.0333	CrCbGaD
Fluoxymesterone—ESR1—Gene Expression—TAF1—Parkinson's disease	0.000873	0.00131	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—NR4A2—Parkinson's disease	0.000873	0.00131	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—NR4A2—Parkinson's disease	0.00086	0.00129	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—TAF1—Parkinson's disease	0.00086	0.00129	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—HTR2A—Parkinson's disease	0.000851	0.00128	CbGpPWpGaD
Fluoxymesterone—Testosterone—ABCB1—Parkinson's disease	0.000844	0.0314	CrCbGaD
Fluoxymesterone—ESR1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000817	0.00123	CbGpPWpGaD
Fluoxymesterone—Dexamethasone—ABCB1—Parkinson's disease	0.000817	0.0304	CrCbGaD
Fluoxymesterone—ESR1—Signaling Pathways—VPS35—Parkinson's disease	0.000806	0.00121	CbGpPWpGaD
Fluoxymesterone—NR3C1—Generic Transcription Pathway—CTGF—Parkinson's disease	0.000805	0.00121	CbGpPWpGaD
Fluoxymesterone—ESR1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000796	0.0012	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—APOE—Parkinson's disease	0.000791	0.00119	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000789	0.00119	CbGpPWpGaD
Fluoxymesterone—NR3C1—AP-1 transcription factor network—IL6—Parkinson's disease	0.000784	0.00118	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL1B—Parkinson's disease	0.00078	0.00117	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Breast Cancer Pathway—CASP3—Parkinson's disease	0.000734	0.0011	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000725	0.00109	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—MAPK8—Parkinson's disease	0.000716	0.00107	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	0.000706	0.00106	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	0.000704	0.00106	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL6—Parkinson's disease	0.000698	0.00105	CbGpPWpGaD
Fluoxymesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—Parkinson's disease	0.000691	0.00104	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL6—Parkinson's disease	0.000687	0.00103	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL23A—Parkinson's disease	0.000687	0.00103	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPL14—Parkinson's disease	0.000687	0.00103	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—INS—Parkinson's disease	0.000676	0.00102	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000675	0.00101	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DGKQ—Parkinson's disease	0.000667	0.001	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GPR37—Parkinson's disease	0.000667	0.001	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—RPS8—Parkinson's disease	0.00064	0.000962	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00061	0.000917	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	0.000608	0.000913	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—TNF—Parkinson's disease	0.000592	0.000889	CbGpPWpGaD
Fluoxymesterone—AR—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000574	0.000862	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	0.000559	0.000839	CbGpPWpGaD
Fluoxymesterone—AR—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000545	0.000818	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—RIT2—Parkinson's disease	0.000534	0.000801	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL23A—Parkinson's disease	0.000529	0.000794	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPL14—Parkinson's disease	0.000529	0.000794	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL23A—Parkinson's disease	0.000521	0.000782	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPL14—Parkinson's disease	0.000521	0.000782	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA8—Parkinson's disease	0.000513	0.00077	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	0.000512	0.000769	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—CTGF—Parkinson's disease	0.000511	0.000767	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRK5—Parkinson's disease	0.000506	0.00076	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—CASP3—Parkinson's disease	0.000503	0.000756	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—RPS8—Parkinson's disease	0.000493	0.000741	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—RPS8—Parkinson's disease	0.000486	0.000729	CbGpPWpGaD
Fluoxymesterone—NR3C1—Adipogenesis—IL6—Parkinson's disease	0.000478	0.000718	CbGpPWpGaD
Fluoxymesterone—AR—Gene Expression—HSPA1A—Parkinson's disease	0.000467	0.000701	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—MAPK8—Parkinson's disease	0.000463	0.000695	CbGpPWpGaD
Fluoxymesterone—PRLR—Immune System—IL6—Parkinson's disease	0.000457	0.000686	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM4—Parkinson's disease	0.000454	0.000681	CbGpPWpGaD
Fluoxymesterone—ESR1—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	0.000442	0.000664	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAG—Parkinson's disease	0.00043	0.000646	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PENK—Parkinson's disease	0.00043	0.000646	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling by ERBB4—IL6—Parkinson's disease	0.000428	0.000643	CbGpPWpGaD
Fluoxymesterone—NR3C1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	0.000413	0.00062	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA8—Parkinson's disease	0.000395	0.000593	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—CTGF—Parkinson's disease	0.000393	0.000591	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—PDYN—Parkinson's disease	0.000393	0.000591	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA8—Parkinson's disease	0.000389	0.000584	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—CTGF—Parkinson's disease	0.000387	0.000582	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GFAP—Parkinson's disease	0.00037	0.000555	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—GRM5—Parkinson's disease	0.000366	0.000549	CbGpPWpGaD
Fluoxymesterone—ESR1—Gene Expression—HSPA1A—Parkinson's disease	0.00036	0.00054	CbGpPWpGaD
Fluoxymesterone—NR3C1—Gene Expression—HSPA1A—Parkinson's disease	0.000354	0.000532	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGF20—Parkinson's disease	0.000321	0.000482	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000311	0.000467	CbGpPWpGaD
Fluoxymesterone—PRLR—Signaling Pathways—IL6—Parkinson's disease	0.000295	0.000444	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INSR—Parkinson's disease	0.000287	0.000431	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—FGB—Parkinson's disease	0.000271	0.000407	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR1A—Parkinson's disease	0.00027	0.000405	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—TAC1—Parkinson's disease	0.000266	0.000399	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD1—Parkinson's disease	0.000261	0.000391	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD3—Parkinson's disease	0.000252	0.000379	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000236	0.000354	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR7—Parkinson's disease	0.000228	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—DRD2—Parkinson's disease	0.000228	0.000343	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF2—Parkinson's disease	0.000191	0.000287	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IGF1R—Parkinson's disease	0.000185	0.000278	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—EDN1—Parkinson's disease	0.000183	0.000274	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—NGF—Parkinson's disease	0.000168	0.000252	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—HTR2A—Parkinson's disease	0.00016	0.00024	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—APOE—Parkinson's disease	0.000149	0.000223	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—INS—Parkinson's disease	0.000127	0.000191	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—CASP3—Parkinson's disease	9.45e-05	0.000142	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—MAPK8—Parkinson's disease	8.69e-05	0.00013	CbGpPWpGaD
Fluoxymesterone—ESR1—Signaling Pathways—IL6—Parkinson's disease	5.55e-05	8.33e-05	CbGpPWpGaD
